Tag Archives: Cancer

University of Freiburg spin-off with strong preclinical evidence for significant breakthrough in curing prostate cancer

FREIBURG, Germany, 1-Jul-2021 — /EPR HEALTHCARE NEWS/ — Prostate cancer is the second most common cancer. According to the American Cancer Association, 1 in every 8 men will be diagnosed with it in their lifetime. In 2018 around 1.2 million men were diagnosed and there were 360,000 deaths. In Europe alone, 450,000 men are diagnosed with prostate cancer every year. But there could be a cure on the horizon.

B66, a new company in Germany and a spin-off from the University of Freiburg, Germany, has strong preclinical evidence that its research has made a significant breakthrough after 6 years of dedicated work. Professors Roland Schule, Manfred Jung and Dr Eric Metzger have pioneered research into inhibitors of the histone methyltransferase KMT9 that controls the growth of castration and enzalutamide resistant prostate tumours. These small molecular inhibitors are superior to current state-of-the-art Gold Standard drugs in preclinical models. This new treatment has the prospect of increasing survival in the normally fatal outcome of castration-resistant prostate cancer and becoming the universal therapeutic agent. In addition, the research team’s work shows that their new therapeutic agent has potentials in other cancers including colorectal, breast, bladder and the biggest of all killers, lung cancer.

Professor Roland Schule, one of the B66 founders, and a professor of Biochemistry in the University Medical Centre of Freiburg said “Our findings and approach to treatment is far in advance of anything that is going on in the world at the moment.”

Fellow founder, Professor Manfred Jung, added “many cancer treatments cause damage to the patient’s normal cells but the B66 inhibitor does not target normal cells indicating that our treatment will have minimum side effects”.

Although focused on prostate cancer right now, the B66 team’s long-term objective is to create a world-class development platform that will work on the defeat of many other types of cancer. The Freiburg region, thanks to the University, is a unique centre of leading medical knowledge. B66 will expand their work and draw in some of the skilled scientists from the area to help them work towards building a leading medical development hub.

The B66 team is already seeking commercial partners in order to forward their breakthrough work and advance as quickly as possible to defeat this major cancer.

SOURCE: EuropaWire

First Rhenium-SCT® (Skin Cancer Therapy) treatment in Germany done by Dr. Lutz-Hendrik Holle

HANAU, Germany, 4-Oct-2019 — /EPR HEALTHCARE NEWS/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today, that Dr. Lutz-Hendrik Holle, Medical Director of the interregional professional association for nuclear medicine in Hanau, has accomplished the first Rhenium-SCT® (Skin Cancer Therapy) treatment in Germany. This state-of-the-art technology of local radionuclide therapy offers a painless and non-invasive treatment option for patients with basal cell carcinoma and squamous cell carcinoma (BCC and SCC) and the interregional professional association for nuclear medicine Hanau is the first center in Germany that offers the Rhenium-SCT®.

With approximately 50.000 outpatient examinations annually, the interregional professional association for nuclear medicine Hanau is one of the biggest nuclear medicine service providers in Hesse. The offered services include a variety of different modern treatment and diagnostic methods. The key argument for the expansion of the spectrum was that the Rhenium-SCT® is a new, painless and highly efficient treatment option that also delivers excellent cosmetic results. Besides being a painless alternative to other procedures, the Rhenium-SCT® also allows the treatment of numerous NMSC lesions consecutively in a single session, which was already realized during the first treatment in Hanau. This has also attracted international attention so that an American patient travelled to Hanau for the treatment.

“This therapy is particularly suitable for tumor localizations where good cosmetic results are to be achieved. The fact that the treatment is completely painless and can be performed in just one session is a great advantage”, says Dr. Lutz-Hendrik Holle, Medical Director of Nuclear Medicine in Hanau.

“We are very happy and proud to be able to offer our revolutionary treatment to patients in Germany now. The interregional professional association of nuclear medicine in Hanau is an excellent partner for NMSC patients in the fight against NMSC”, said Shannon D. Brown III, CEO and Managing Director of OncoBeta® GmbH. “Unfortunately, Germany is one of the countries that has experienced a drastic increase in newly diagnosed NMSC cases in recent years. Our highly qualified team strives to provide physicians and patients with a non-invasive and affordable solution to treat NMSC, while focusing on the needs of the patient.”

The global incidence of non-melanoma skin cancers has been drastically increasing over the past decades. Depending on the source, it is estimated that there are over 5 million non-melanoma skin cancer cases reported globally each year. In certain analyzed areas of Germany there was an increase in the incidence between the year 2005 and the year 2014 by about 30%1. To serve the increasing medical need for innovative therapies in this field and to improve the quality of patients’ lives, OncoBeta® GmbH has developed its innovative Rhenium-SCT® which only require a single application in most of the cases, applied in one single session with excellent aesthetic outcomes.

Via EPR Network
More Healthcare press releases

2019 Red Herring North America Top 100 Winner: New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients

Pasadena, CA, U.S.A., 6-Jul-2019 — /EPR HEALTHCARE NEWS/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today, that it was honored as a Red Herring Top 100 North America Award winner recognizing the continent’s most exciting and innovative private technology companies. After being recognized with the Red Herring Top 100 Europe Award earlier this year, this is now the second recognition obtained by Red Herring.

The winners, celebrated at a special awards ceremony at the Westin Pasadena hotel, have been chosen from thousands of entrants, whittled down to hundreds making the trip to California. The ceremony, led by Red Herring chairman Alex Vieux, was preceded by two days of keynote speeches, discussions and finalist presentations.

Companies were judged by industry experts, insiders and journalists on a wide variety of criteria including financial performance, innovation, business strategy, and market penetration. Winners ran the gamut of verticals, from FinTech and Marketing to Security, IoT, and many more industries.

Red Herring’s editors have been evaluating the world’s startups and tech companies for over two decades. It gives them the ability to see through the industry’s hype to pick firms that will continue on a trajectory to success. Brands such as Alibaba, Google, Kakao, Skype, Spotify, Twitter and YouTube have all been singled out in Red Herring’s storied history.

“2019’s crop of Top 100 winners has been among our most intriguing yet,” said Vieux. “North America has led the way in tech for so many years, and to see such unique, pioneering entrepreneurs and companies here in California, which is in many ways the heartland of the industry, has been a thrilling experience.”

“What has excited me most is to see so many people forging niches in high-tech and cutting edge sectors,” added Vieux. “Some of the technical wizardry and first-rate business models showcased here at the conference has been fantastic to learn about. We believe OncoBeta® embodies the drive, skill and passion on which tech thrives. OncoBeta® should be proud of its achievement – the competition was incredibly strong.”

“Being named as one of the Red Herring’s Top 100 North America award winner in addition to the Top 100 Europe is a great honor for us.” states Shannon D. Brown III, CEO of OncoBeta®. “The spirit of the award aligns perfectly with our team’s mission in the fight against non-melanocytic skin cancer (NMSC) with the Rhenium-SCT®.”

The complete list of the 2019 Red Herring North America Top 100 Winners can be found here in alphabetical order: https://www.redherring.com/2019-rhna-top100-winners/

Red Herring’s press release is available online at https://www.redherring.com/red-herring-2019-top-100-north-america-winners-press-release/

SOURCE: EuropaWire

The interregional professional association for nuclear medicine in Hanau has become the first treatment center in Germany to offer the Rhenium-SCT® (SCT= Skin Cancer Therapy)

GARCHING N. MUNICH, Germany, 13-May-2019 — /EPR HEALTHCARE NEWS/ — OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), is pleased to announce that the interregional professional association for nuclear medicine in Hanau now offers the Rhenium-SCT ® (SCT= Skin Cancer Therapy) as the first treatment center in Germany.

With approximately 50.000 outpatient examinations annually, the interregional professional association for nuclear medicine Hanau is one of the biggest nuclear medicine service providers in Hesse. The offered services include a variety of different modern treatment and diagnostic methods which are state-of the art in science and technology.

“Offering NMSC skin cancer patients a highly efficient, painless, innovative therapy with excellent aesthetic results was the driving reason to establish this treatment method in our clinic,” says Dr. med. Lutz-Hendrik Holle, Medical Director of Nuclear Medicine in Hanau.

“We are delighted that our innovative skin cancer therapy Rhenium-SCT® is now being offered by the Nuclear Medicine in Hanau and we are looking forward to this collaboration”, states Shannon D. Brown III, CEO and Managing Director of OncoBeta® GmbH. “For us, this is an important step to offer the treatment method in addition to Italy, South Africa and Australia now also in Germany. In order to provide our treatment to as many skin cancer patients as possible, it is of course our goal to offer the availability of the therapy nationwide in Germany in the future.”

The global incidence of non-melanoma skin cancers has been drastically increasing over the past decades. Depending on the source, it is estimated that there are over 5 million non-melanoma skin cancer cases reported globally each year. In Germany the number of newly diagnosed patients is about 200,000 annually and it is assumed that this number increases within the next years. To serve the increasing medical need for innovative therapies in this field and to improve the quality of patients’ lives, OncoBeta® GmbH has developed its innovative Rhenium-SCT® which only require a single application, applied in one single session with excellent aesthetic outcomes.

If interested, patients and doctors can either contact the interregional professional association for nuclear medicine in Hanau directly or OncoBeta® GmbH.

SOURCE: EuropaWire

University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin #Cancer Patients with Rhenium-SCT®

Garching n. Munich, Germany, 26-Nov-2018 — /EPR HEALTHCARE NEWS/ — OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today that Prof. Mike Sathekge from the University of Pretoria, Steve Biko Academic Hospital Nuclear Medical department and his clinical team has treated the first non-melanocytic skin cancer patients in South Africa with the innovative Rhenium-SCT® skin cancer treatment System. This next-generation radionuclide therapy technology applied by the nuclear medicine physician offers a new singles session, painless treatment for patients suffering from Basal Cell – and Squamous Cell Carcinomas (BCCs and SCCs).

The global incidence of non-melanoma skin cancers has drastically increased over the few past decades. Depending on the source, it is estimated that there are over 5 million non-melanoma skin cancer cases reported globally each year. Approximately 80% of non-melanoma skin cancers are basal cell carcinomas or squamous cell carcinomas with South Africa having one of the highest incidence rates in the world.

Prof. Mike Sathekge and his team at the University of Pretoria, Steve Biko Academic Hospital are focused on providing patients with personalized care using state-of-the-art technology that can deliver high-precision therapy and diagnostics with minimal side effects. The specialized team of experts in the nuclear medicine and medical physics, work closely with other disciplines within the university hospital, referring physicians, and other institutions, to ensure patients receive the best possible treatment for their specific type of cancer.

Martin Magwaza, CEO of Tautomer (PTY) LTD Oncobeta®’s distribution partner for the Rhenium-SCT® in Africa, is dedicated to providing South Africans with new innovative and effective therapies across the continent, coordinating with representatives from all levels of government and state for the health care landscape.

“The start of the Rhenium-SCT® in South Africa is a significant milestone in the international expansion of our ground-breaking treatment for BCCs and SCCs.,” said Shannon D. Brown III, CEO and Managing Director of OncoBeta® GmbH. “Our vision of bringing a revolutionary affordable skin cancer therapy to physicians and patients all over the world has come one step closer today”.

SOURCE: EuropaWire

The End of Alzheimer’s? A revolutionary scientific advance to the cure

Interface Dynamics Control Corporation (IDCC) has completed the first phase of its decade-long Advanced Therapeutic Interventions Project, with the result that a new approach to arresting and curing Alzheimer’s disease and the other neurodegenerative diseases has been produced and verified. IDCC is now launching the Project’s second phase, which will validate the first phase findings.

Alzheimer’s disease is the sixth leading cause of death in the United States, with more than 5.1 million Americans currently affected. The direct cost of Alzheimer’s is greater than $200 billion annually, a number expected reach between $1.2 and $1.5 trillion by 2050. Indirect costs are substantial: more than 15 million caregivers delivered some 17.5 billion hours of unpaid care valued at more than $200 billion.

IDCC has discovered the mechanism of and means to control the protein misfolding, abnormal aggregation, and degradation processes associated with the degenerative and prion diseases. That mechanism is also implicated in the failure to clear toxic intracellular proteins and in the dysfunction of apoptotic (programmed cell death) pathways. It underlies the adverse functions of the neuroglia (glial cells), including microglia, which provide immune defense to the central nervous system (CNS) and maintain homeostasis and protection for neurons in the brain and the peripheral nervous system.

The process of neurodegeneration has not been understood previously, which has precluded the production of any arresting or curative procedures or drugs. The Project’s findings, however, should lead to the realization of a new class of curative procedures and pharmaceuticals which can be engaged to defeat the disease-initiating neurodegenerative insult, thereby introducing the possibility of preventing these devastating diseases. There are direct implications for the human cancers, but verification of those implications must await further experiments.

The first major activity under the Project’s second phase will be the production of a new class of active imaging system. That system will be utilized to demonstrate the activities and accessible control points of the process pathways which, when certain abnormal events occur, trigger the incipient causal mechanisms of disease. The Project is currently developing the staff and capitalization required for execution of its second phase.

About IDCC 
IDCC was founded thirteen years ago to produce definitive solutions to seemingly intractable problems of social and technological significance. It is privately held and maintains its projects and client identities in strict confidence unless and until information releases are authorized by competent authority.

Contact Details: Peter W. Atkinson
IDCC
4655 Logsdon Drive
Annandale, VA 22003-3564 USA
+1.703.879.7065
Peter@InterfaceDynamicsControl.com

Via EPR Network
More Healthcare press releases

Bupa Launches Series Of Cancer Support Booklets For Children

Bupa has launched a series of booklets to support children when someone close to them has cancer. The booklets are free and available to all and have been developed through consultation with children and the advice of specialists, including Bupa’s cancer experts.

Child psychologist Professor Tanya Byron has today said that more emotional support is needed for families dealing with cancer, highlighting the difficulty of helping children to understand the illness. She said: “When we as adults receive information that is devastating to deal with, it’s almost harder to tell our children than it is to hear it ourselves. But research has shown that by not talking at all, in order to avoid the painful truth, many parents may be causing excessive levels of anxiety for their children when there are simple steps to manage this.

“Up until now there has been little advice available to help with this problem, which is why these new booklets, available now, are such an important initiative.”

The series of four booklets, called ‘I Know Someone with Cancer’, are aimed at 7-11 year olds. They explain cancer and treatments in a simple and sensitive way, using language and visuals that children can relate to. They also offer children ideas for dealing with their feelings and helping their family in small ways, as well as activities to occupy them at home or at hospital. They can be read independently by the child or used as a guide for discussion.

The initiative is also supported by actor Stephen Mangan, who has been personally affected by cancer and has young children of his own.

Stephen Mangan said: “My family has been affected by cancer and I’ve seen how hard it is to talk about the illness with loved ones. Now I have two young children I have wondered what I would do in that situation. These booklets are a wonderful tool to help with a very difficult conversation, to help children understand what the adult with cancer is going through and how to cope with their feelings about it.”

Dr Katrina Herren, medical director, Bupa Health and Wellbeing, said: “It can be very confusing and frightening for a child to find out someone they love is ill with cancer. We have set out to create something that children can understand and read in their own time and share with their friends and family.”

Bupa’s dedicated Oncology Support Team takes over 10,000 calls per month from people with cancer and their relatives, who often seek advice on the many emotional, physical and practical difficulties associated with cancer.

Bupa has been providing expert cancer care for over 60 years, funding treatment for over 23,000 people per year and follow-ups and support for an additional 20,000 cancer survivors who have been treated for cancer in the past.

The ‘I Know Someone with Cancer’ series can downloaded from www.bupa.co.uk/iknowsomeonewithcancer.

Via EPR Network
More Healthcare press releases

Gene Therapy and Stem Cell Therapy Standard Developed For A Unique Derivative Of Post Hetero-Plastic Inplantation Chronic Inflammation Syndrome, The NIDO Disease

Researchers task force, led by faculties of T-Protocol, registered Genom Project as controlled genom project in the hosted database of NCBI, a publication matter authority and function assigned organization under oversee of Department of Health & Human Services, reached once to share the exegetical impression officially pre-published concerning the understanding specific spectrum of symptoms covering boroad range of character usually complained and observed through chronic inflammation, granuloma, some types of lymphoma and various uncommon symptoms to let physician scientists suspecting indicium of neurological diseases, NIDO disease, an unique type of post hetero-plastic implantation chronic inflammation syndrome and setting Massachusetts indications of treatments standardized manual (Massachusetts manual) & diagnostic and standardized medical treatment manual for post hetero-plastic inplantation chronic inflammation syndrome, specific edition against NIDO Disease.

The once defined causes of NIDO disease, an unique type of post hetero-plastic implantation chronic inflammation syndrome are considered each of a common living organism to cause conformational diseases like Creutzfeldt-Jakob disease, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and kinds of and a set of biochemical and physical reaction and response realized by cross-species gene- mutation, as biotransformation, easily describing natural physiological and biochemical changes in vivo substrate of human bodies. After this studies, standardized protocol of gene therapy and applied stem cell therapy is now in practice and on available.

Faculties,committing themselves entirely to the project, of each institutes and organizations participating the project to ascertain proteins and DNA/genomic DNA/genom of human, other mammal and virulent microorganism including bacillus/virus affecting each symptom and the symptoms’ spectrum expressed generally and observed commonly on patients suffered from NIDO disease, extraordinarily unique derived type of post hetero-plastic implantation chronic inflammation syndrome and to develop diagnostic standard and treatment protocol standardized and to find a clue compose gene therapy protocol and applied stem cell therapy protocol to entirely heal NIDO disease, an unique type of post hetero-plastic implantation chronic inflammation syndrome and to let all of current suffered patients from various combined symptoms directly derived by chronic inflammation and various tumors, have to express full surprise at the fact that these disease and patients suffered are made up and left no attention and no relief.

Via EPR Network
More Healthcare press releases

Quoteboffin.co.uk Urges Health Providers To Maintain Momentum In Light Of Improving Cancer Survival Rates

Survival rates for some cancers has doubled since the 1970s. Now health and life insurance comparison site, QuoteBoffin.co.uk, is calling on health organisations to continue their good work.

Following research by leading organisation Cancer Research UK, it has emerged that survival rates for some cancers including bowel, breast and ovarian have doubled over the past four decades.

Comparisons between survival rates for those with cancer in the 1970s and people with the disease in the late noughties show vast improvements in the number of patients expected live more than ten years with the disease.

Breast and bowel cancer have seen remarkable improvements in survival rates with the number of people living at least ten after diagnosis years jumping from 40% to 77% and 23% to over 50% respectively.

Despite the improvements, health organisations and cancer charities are still calling for more work to be done to improve cancer patients chances of survival.

A spokesperson from QuoteBoffin.co.uk joined the calls for further research, with cancer treating drugs high on the agenda:

“It’s encouraging to see such a stark improvement in cancer survival rates in such a short space of time.

“As technology improves so does our ability to detect and treat cancer earlier and earlier and this brings with it its own set of problems.

“No longer is cancer treatment about prolonging a patient’s life, it’s about completely curing the disease altogether so now we must put more and more money and time into crafting and fine tuning a range of drugs and treatments that can be applied to the disease at any stage.”

Via EPR Network
More Healthcare press releases

LighterLife Launches Listen And Learn Podcast Service

LighterLife, the industry leading weight loss and weight-management company, has released the first of a series of monthly podcasts, designed to help people learn how to live healthier, lighter lives.

Titled ‘Inside LighterLife’, this is the place to listen to tips, advice and features on how to lose weight quickly and safely, as well as interviews with health experts, LighterLife Weight-Management Counsellors and real-life people who have struggled with their weight.

Unscripted, conversational and honest – like a morning TV chat show on the run – the first podcast sees host Susan Spence, a multi-skilled presenter who can also be heard on LBC, Radio Five Live and the Steve Allen Show chatting to Dr Hilary Jones about some pressing weight-related medical questions, talking to LighterLife Weight-Management Counsellor Lindsey Thompson-Wright from Loughton, Essex about the stories behind the weight loss of some of her clients and meeting with Rachel Drago, an inspirational client who tells why she believes LighterLife literally saved her life.

Rachel Drago hit the headlines a few months ago after losing five stone with LighterLife and losing 10 inches of fat off her breasts allowed her to discover a lump in her breast that was subsequently diagnosed as breast cancer. Plus listeners will be able to hear how 12 overweight men’s 52 stone weight loss with LighterLife gave them the confidence to strip naked and bare all to raise money for The Prostate Cancer Charity.

Upcoming episodes of the new weight loss podcast, Inside LighterLife, will include further expert advice from Psychotherapist Annie Wilson who will discuss some of the psychological reasons behind overeating, more inspirational weight-loss stories and advice and encouragement for overweight and obese people to lose weight and maintain a healthy lifestyle.

Available to download free from iTunes, podcast directories and the LighterLife website, Inside LighterLife gives clients the opportunity to listen to and identify with the experiences of others on the programme. For many clients it will offer a motivational boost and for others it will provide the support they need when they are having a weak moment.

As well as allowing clients to listen and learn more about LighterLife, Inside LighterLife also offers potential clients an inside look into a programme that has helped 150,000 people lose weight and keep it off.

Sara Jamison, CEO, LighterLife commented: “Inside LighterLife is another fantastic additional service that we are offering to both LighterLife clients and all those people out there who have struggled with their weight or who are losing weight using other methods. Listeners will be able to learn more about LighterLife from the people who have actually lived, breathed and succeeded on it, have their questions answered by the experts and listen to tips and advice that will help them live lighter, happier lives and we can’t wait to hear the feedback.”

Via EPR Network
More Healthcare press releases

LighterLife Has Produced A Brand New Calendar To Help Raise Money For The Prostate Cancer Charity

LighterLife has produced a brand new calendar to help raise money for the Prostate Cancer Charity. The calendar features 12 men who have lost weight with LighterLife baring all for the cameras.

These brave men, from various walks of life had a variety of personal reasons for losing weight which ranged from being able to keep up their kids and reducing the risk of bad health, through to wanting to apply to become a fireman. What brought these men together was that they all had the same goal; to lose weight with LighterLife. With their lives changed for the better, they stripped down to not only celebrate their amazing weight loss, but to also raise money and awareness for a charity close to their hearts.

Lee, who posed for the month of January, lost six stone and is now running rings around his young football team. Gary, otherwise known as Mr. February, is six stone lighter and no longer lags behind the rest of his walking group. Lee, or Mr. March, has lost the five stone he put on after being diagnosed with testicular cancer.

Mark, who can be seen in the calendar in April, has a new lease on life and can keep up with his kids after losing four stone. Mike, or Mr. May, is no longer clinically obese and since losing just under three stone, is a faster and more confident water polo player. Five stone lighter, Nuno, or Mr. June, now has the confidence and the BMI to apply for his dream job as a fireman.

Former yo-yo dieter Phil, who posed for July, lost three stone which has given him the confidence to do what he loves – DJ’ing. Steven, or Mr. August, can now enjoy a full game of football without feeling tired and Rod, who features in September, is now training for a triathalon to help maintain his five stone weight loss.

LighterLife weight-management Counsellor Gina Lennon, who coordinated the men during the calendar photo shoot, said: “I’m delighted to have been involved in this project. There has been a great deal of interest and this has definitely put the fun back into fundraising. The calendar boys have achieved so much – losing such large amounts of weight, maintaining their weight loss, overcoming fears about their body image and baring all to raise money for a very worthwhile charity.”

Via EPR Network
More Healthcare press releases

International Masters Publishers, Inc., On Behalf Of Its Collection Of Health And Well-Being Products Has Made A Donation To Rocking The Road For A Cure, Inc.

International Masters Publishers, Inc., on behalf of its collection of Health and Well-being products has made a donation to “Rocking the Road for a Cure, Inc.” — a non-profit organization founded to provide free education and support services for women and men going through the diagnosis and treatment of breast cancer.

Reflecting their strong commitment to providing valuable health information, International Masters Publishers, Inc. (IMP) recently announced its continuing support for breast cancer research and wellness programs through its contribution to the community-based non-profit organization “Rocking the Road for a Cure, Inc.”

Founded by Dawn Frey after she was diagnosed with breast cancer, “Rocking the Road for a Cure, Inc” provides free support services aimed to enhance the coping skills of those in treatment, and expand the support networks that have proven so essential to their quality of life. These services include:

• Homebound Yoga, Reiki and massage
• Medical case management assistance
• Homebound Recreational Therapy
• Beauty consultations
• Nutrition advice and services

“We are proud to support the great work done by Rocking on the Road for a Cure, Inc.”, says Dilenia Chireno, IMP Spokesperson, “their programs use many of the same approaches to self-empowerment we cover in our collections, so it’s really an excellent fit for us. We are so proud to be part of this important and worthwhile cause.”

In addition to its generous corporate donation, IMP will also offer some customers of The Complete Guide to Natural Healing and Enhancing Your Mind Body Spirit the opportunity to make an additional donation by contributing a portion of the proceeds it receives from these two products to this great cause.

Via EPR Network
More Healthcare press releases

The Facts About Heart Disease

  • Heart Disease has been the number 1 killer in the US every year since 1900 with the exception of 1918.

  • At least 250,000 Americans die of heart attacks each year before they reach the hospital.

  • Every 34 seconds someone in the US dies from Heart Disease.

  • Heart Disease can be avoided with good nutrition.
If you are as little as 10 pounds overweight you are at risk forHeart Disease.Chronic Diseases cost the US economy 1.3 trillion dollars annually and this could reach 6 trillion by the middle of the century.

Reduce the Risk of Heart Disease for you and your loved ones. Over and over again I hear success stories of how people who have used our science based, nutritional products to lose weight. But not only do they lose weight but they are lowering their cholesterol levels, stabilizing blood pressure and sugar levels and are getting off of medications they have been taking for years. We have had people say they have gotten rid of allergies, migraines, joint pain and more. Good Nutrition allows your body to heal. (individual results vary). You can gain weight, lose weight, or maintain weight with our products. Our products do come with a guarantee.

My mother and father have both had open heart surgery. It is not a fun thing to go through. The thought of having your breast bone broken in half and raised in vertical position for hours is not a pretty picture to me. I do not wish to ever need this surgery and I am here to help you, in hopes that you do not ever need it as well.

Good Nutrition affects everything:

  • health

  • energy

  • organs

  • cells

  • vitality

  • skin

  • quality of life

The American Medical Association has said that 70% of medical conditions are diet related.

Here are a few common diseases that may be prevented with proper diet and or maintaining a healthy weight.

Cancer: breast, uterus, cervix, colon, esophagus, pancreas, kidney and prostrate
Coronary Heart Disease, Diabetes, Dyslipidemia, hypertension
Idiopathic Intacraial hypertension, stroke, cataracts
Osteoarthritis, skin, gout, phlebitis
Gynecologic Abnormalities, abnormal menses,infertility, poly cystic ovarian syndrome
Gall Bladder Disease
Pulmonary Disease
Obstructive Sleep Apnea
Hypo ventilation Syndrome
Severe Pancreatitis
Non Alcoholic Fatty Liver Disease

If you truly want to feel good and enjoy quality of life you need to get started with Core Nutrition. Once you receive your Core Nutrition, I will send you a personalize your program DVD (FREE), I will give you personalized coaching on a regular basis (FREE) to help you achieve your wellness goals, and you will receive a FREE Wellness Evaluation. A Wellness Evaluation will help you learn better dieting habits as well as give you a better understanding about where you are at with your health and wellness. We will be able to determine what your goals are and come up with some recommendations that will help you be able to enjoy a better quality of life.

Once you get started with our Core Nutrition or Weight Loss Program you may find that you are saving money on your prescriptions plus doctor and hospital bills. You may even be earning more money because you are missing work less and are able to work longer hours.

Via EPR Network
More Healthcare press releases

Field Fisher Waterhouse has recovered compensation for the cost of a claimant’s hospice care in a case that is though to be the first of its kind

Field Fisher Waterhouse (FFW), the full service European law firm, has recovered the value of the hospice care that was required by a claimant. This is thought to be the first case of its kind, with most hospices generally exclusively funded by charitable donations. As part of the settlement, the firm was able to recover £12,500 to be paid over to the hospice.

The case arose out of the death of a 64 year old man due to mesothelioma, an asbestos-related cancer, in December 2007 after spending his final days being cared for in a North London Hospice dedicated to cancer patients.

Through his life the man suffering from the cancer had worked as a carpenter, painter and labourer. In 1963, whilst employed as a painter for J Murphy & Sons Ltd, he was exposed to asbestos dust whilst sanding down and filling in walls in prefabricated housing containing asbestos. He was then exposed to further asbestos when working for the same company at a factory in Dagenham, cleaning debris from the guttering on roofs made from corrugated asbestos.

In August 2005 he was diagnosed with mesothelioma, an asbestos related cancer on the lining of one of his lungs. He was eventually admitted to the hospice where he spent the last month of his life.

Rodney Nelson-Jones, partner in the Asbestos Claims Group at Field Fisher Waterhouse, was instructed to claim compensation on behalf of the man’s family. The firm was able to recover £170,000 from J Murphy & Sons Ltd, £12,500 of which is being paid to the hospice which provided him with care worth over £400 a day.

This is thought to be the first time that compensation has been recovered for a patient’s hospice care, which is usually funded by charitable donations. It has long been possible to recover compensation for the value of care provided by relatives but FFW’s innovation has been to extend this principle to charitable care provided by hospices. The firm plans to continue to claim the cost of hospice care in future mesothelioma cases.

Rodney Nelson-Jones commented: “We are delighted to have been able to secure extra funding for the hospice. Hospices do a wonderful job and rely on charitable donations to provide much needed palliative care for cancer patients. We hope that this case will mean that they are now provided with an additional source of funding.”

About Field Fisher Waterhouse
Field Fisher Waterhouse LLP is a full-service European law firm with offices in Brussels, Hamburg and London. With 119 partners, over 200 other lawyers and nearly 300 support staff, FFW assist a wide range of international clients, advising across a full range of legal issues.

The main areas of practice are corporate and commercial, IP and technology, banking and finance, regulatory and real estate. Field Fisher Waterhouse LLP also have particular expertise in competition & EU law, dispute resolution, employment, asbestos and mesothelioma claims, personal injury cases and clinical negligence, public sector and tax.

Via EPR Network
More Healthcare press releases

“2008 Breaking Boards For Breast Cancer” At Waterfire In Providence To Support The Gloria Gemma Breast Cancer Foundation

In recognition of Breast Cancer Awareness Month, Mastery Martial Arts will sponsor a fundraising event to “break boards” on October 11, 2008. Join a community of supporters at the Waterfire of Providence event to benefit people living with breast cancer.

Mr. Greg Horton, founder of Mastery Martial Arts will have his black belt instructors demonstrate the breaking of boards in rapid fire succession in the exhilarating celebration and symbolic ritual of empowering women to harness the fight. The broken boards will be placed in the Waterfire brassieres while you watch your special message and wishes become spiritually delivered through the tranquil burning of this special WaterFire of Providence celebration.

In a dramatic ending, over 300 torch bearers will unite and illuminate the Rhode Island state house in pink to show the dedication and strength in fighting for a cure.

Donations can be made by purchasing a board ($5.00) or a block of wood ($50.00), or a simple donation complimented by a personal message or wish for someone suffering from breast cancer. The funds raised will go to the Gloria Gemma Breast Cancer Foundation to support breast cancer awareness and generate funding for critical breast health programs.

Visit http://www.firstgiving.com/bonitaboutin/ to make your donation today.

About Us:
Bonita Boutin, the Rhode Island organic skin care impresario understood early on how she could motivate and inspire women to celebrate life and achieve strength from within. Because of her personal family experiences with breast cancer, Bonita Boutin is dedicated to providing breast cancer support and awareness to women throughout the world.

Bonita Boutin founded Bonita Botanicals Skin Care in Rhode Island to holistically raise the quality of life for adults and students through organic and natural living. In addition to martial arts being enjoyable and satisfying Bonita equates the sport as being a confidence booster and a way to advocate and inspire women to harness the power to fight. She is particularly dedicated to helping fight breast cancer and celebrate life in Providence RI.

Visit Bonita’s breast cancer blog at www.breastcancernews.brighterplanet.org and get inspired to join a passage in seeking answers and finding a cure.

Via EPR Network
More Healthcare press releases